Brian Musolf

Brian Musolf

Mayer Brown

Contact
View Bio
RSS

Latest Posts › Administrative Procedure Act

Share:

In Neurelis v. Brenner, The FDA’s “Indication-Specific” View of Orphan Exclusivity is (Again) Struck Down

The legal battle over the scope of orphan drug exclusivity continues, as the U.S. Food and Drug Administration (“FDA”) has recently lost a second case concerning the exclusivity provisions of the Orphan Drug Act (“ODA”)....more

8/1/2025  /  Administrative Procedure Act , Appeals , Chevron Deference , FDA Approval , Food and Drug Administration (FDA) , Loper Bright Enterprises v Raimondo , Orphan Drugs , Pharmaceutical Industry , Rulemaking Process , Statutory Interpretation
1 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide